- Browse by Author
Browsing by Author "Morisaki, Jorge"
Now showing 1 - 6 of 6
Results Per Page
Sort Options
Item Correction to: Multidimensional insights into the repeated electromagnetic field stimulation and biosystems interaction in aging and age-related diseases(BMC, 2022-09-09) Perez, Felipe P.; Bandeira, Joseph P.; Perez Chumbiauca, Cristina N.; Lahiri, Debomoy K.; Morisaki, Jorge; Rizkalla, Maher; Medicine, School of MedicineCorrection to: Journal of Biomedical Science (2022) 29:39 https://doi.org/10.1186/s12929-022-00825-yItem Electromagnetic and Thermal Simulations of Human Neurons for SAR Applications(Scientific Research Publishing, 2016-08) Perez, Felipe; Millholland, Gilbert; Peddinti, Seshasai Vamsi Krishna; Thella, Ashok Kumar; Rizkalla, James; Salama, Paul; Rizkalla, Maher; Morisaki, Jorge; Rizkalla, Maher E.; Department of Medicine, IU School of MedicineThe impact of the electromagnetic waves (EM) on human neurons (HN) has been under investigation for decades, in efforts to understand the impact of cell phones (radiation) on human health, or radiation absorption by HN for medical diagnosis and treatment. Research issues including the wave frequency, power intensity, reflections and scattering, and penetration depths are of important considerations to be incorporated into the research study. In this study, computer simulation for the EM exposure to HN was studied for the purpose of determining the upper limits of the electric and magnetic field intensities, power consumption, reflections and transmissions, and the change in temperature resulting from the power absorption by human neurons. Both high frequency structural simulators (HFSS) from ANSYS software, and COMSOL multi-physics were used for the simulation of the EM transmissions and reflections, and the temperature profile within the cells, respectively. For the temperature profile estimation, the study considers an electrical source of 0.5 watt input power, 64 MHz. The EM simulation was looking into the uniformity of the fields within the sample cells. The size of the waveguide was set to be appropriate for a small animal model to be conducted in the future. The incident power was fully transmitted throughout the waveguide, and less than 1% reflections were observed from the simulation. The minimum reflected power near the sample under investigation was found to be with negligible reflected field strengths. The temperature profile resulting from the COMSOL simulation was found to be near 0.25 m°K, indicating no change in temperature on the neuro cells under the EM exposure. The paper details the simulation results for the EM response determined by HFSS, and temperature profile simulated by COMSOL.Item Electromagnetic Field Stimulation Therapy for Alzheimer’s Disease(Wolters Kluwer, 2024) Perez, Felipe P.; Morisaki, Jorge; Kanakri, Haitham; Rizkalla, Maher; Medicine, School of MedicineAlzheimer's disease (AD) is the most common neurodegenerative dementia worldwide. AD is a multifactorial disease that causes a progressive decline in memory and function precipitated by toxic beta-amyloid (Aβ) proteins, a key player in AD pathology. In 2022, 6.5 million Americans lived with AD, costing the nation $321billion. The standard of care for AD treatment includes acetylcholinesterase inhibitors (AchEIs), NMDA receptor antagonists, and monoclonal antibodies (mAbs). However, these methods are either: 1) ineffective in improving cognition, 2) unable to change disease progression, 3) limited in the number of therapeutic targets, 4) prone to cause severe side effects (brain swelling, microhemorrhages with mAb, and bradycardia and syncope with AchEIs), 5) unable to effectively cross the blood-brain barrier, and 6) lack of understanding of the aging process on the disease. mAbs are available to lower Aβ, but the difficulties of reducing the levels of the toxic Aβ proteins in the brain without triggering brain swelling or microhemorrhages associated with mAbs make the risk-benefit profile of mAbs unclear. A novel multitarget, effective, and safe non-invasive approach utilizing Repeated Electromagnetic Field Stimulation (REMFS) lowers Aβ levels in human neurons and memory areas, prevents neuronal death, stops disease progression, and improves memory without causing brain edema or bleeds in AD mice. This REMFS treatment has not been developed for humans because current EMF devices have poor penetration depth and inhomogeneous E-field distribution in the brain. Here, we discussed the biology of these effects in neurons and the design of optimal devices to treat AD.Item EMF Antenna Exposure on a Multilayer Human Head Simulation for Alzheimer Disease Treatments(Scientific Research, 2022) Perez, Felipe P.; Rahmani, Maryam; Emberson, John; Weber, Makenzie; Morisaki, Jorge; Amran, Farhan; Bakri, Syazwani; Halim, Akmal; Dsouza, Alston; Yusuff, Nurafifi Mohd; Farhan, Amran; Maulucci, James; Rizkalla, Maher; Medicine, School of MedicineIn this paper, we follow up with our preliminary biological studies that showed that Repeated electromagnetic field stimulation (REMFS) decreased the toxic amyloid-beta (Aβ) levels, which is considered to be the cause of Alzheimer's disease (AD). The REMFS parameters of these exposures were a frequency of 64 MHz and a Specific absorption rate (SAR) of 0.4 to 0.9 W/Kg in primary human neuronal cultures. In this work, an electromagnetic field (EMF) model was simulated using high-frequency simulation system (HFSS/EMPro) software. Our goal was to achieve the EM parameters (EMF Frequency and SAR) required to decrease the toxic Aβ levels in our biological studies in a simulated human head. The simulations performed here will potentially lead to the successful development of an exposure system to treat Alzheimer's disease patients. A popular VFH (very high frequency) patch microstrip antenna system was considered in the study. The selection was based on simple and easy construction and appropriateness to the VHF applications. The evaluation of the SAR and temperature distribution on the various head layers, including skin, fat, dura, the cerebrospinal (CSF), and grey matter, brain tissues, were determined for efficacy SAR and safety temperature increase on a simulated human head. Based on a current pulse of 1 A peak current fed to the antenna feeder, a maximum SAR of 0.6 W/Kg was achieved. A range of 0.4 to 0.6 SAR was observed over the various layers of the simulated human head. The initial design of the antenna indicated an antenna size in the order of 1 m in length and width, suggesting a stationary practical model for AD therapy. Future direction is given for wearable antenna and exposure system, featuring high efficiency and patient comfort.Item Multidimensional insights into the repeated electromagnetic field stimulation and biosystems interaction in aging and age-related diseases(BMC, 2022-06-13) Perez, Felipe P.; Bandeira, Joseph P.; Perez Chumbiauca, Cristina N.; Lahiri, Debomoy K.; Morisaki, Jorge; Rizkalla, Maher; Medicine, School of MedicineWe provide a multidimensional sequence of events that describe the electromagnetic field (EMF) stimulation and biological system interaction. We describe this process from the quantum to the molecular, cellular, and organismal levels. We hypothesized that the sequence of events of these interactions starts with the oscillatory effect of the repeated electromagnetic stimulation (REMFS). These oscillations affect the interfacial water of an RNA causing changes at the quantum and molecular levels that release protons by quantum tunneling. Then protonation of RNA produces conformational changes that allow it to bind and activate Heat Shock Transcription Factor 1 (HSF1). Activated HSF1 binds to the DNA expressing chaperones that help regulate autophagy and degradation of abnormal proteins. This action helps to prevent and treat diseases such as Alzheimer's and Parkinson's disease (PD) by increasing clearance of pathologic proteins. This framework is based on multiple mathematical models, computer simulations, biophysical experiments, and cellular and animal studies. Results of the literature review and our research point towards the capacity of REMFS to manipulate various networks altered in aging (Reale et al. PloS one 9, e104973, 2014), including delay of cellular senescence (Perez et al. 2008, Exp Gerontol 43, 307-316) and reduction in levels of amyloid-β peptides (Aβ) (Perez et al. 2021, Sci Rep 11, 621). Results of these experiments using REMFS at low frequencies can be applied to the treatment of patients with age-related diseases. The use of EMF as a non-invasive therapeutic modality for Alzheimer's disease, specifically, holds promise. It is also necessary to consider the complicated and interconnected genetic and epigenetic effects of the REMFS-biological system's interaction while avoiding any possible adverse effects.Item Numerical Modeling and Computer Simulation of a Meander Line Antenna for Alzheimer's Disease Treatment, a Feasibility Study(Scientific Research Publishing, 2023) Perez, Felipe P.; Rahmani, Maryam; Morisaki, Jorge; Amran, Farhan; Bakri, Syazwani; Halim, Akmal; Dsouza, Alston; Yusuf, Nurafifi Mohd; Farhan, Amran; Maulucci, James; Rizkalla, Maher; Medicine, School of MedicineAlzheimer’s disease (AD) is a brain disorder that eventually causes memory loss and the ability to perform simple cognitive functions; research efforts within pharmaceuticals and other medical treatments have minimal impact on the disease. Our preliminary biological studies showed that Repeated Electromagnetic Field Stimulation (REFMS) applying an EM frequency of 64 MHz and a specific absorption rate (SAR) of 0.4 – 0.9 W/kg decrease the level of amyloid-β peptides (Aβ), which is the most likely etiology of AD. This study emphasizes uniform E/H field and SAR distribution with adequate penetration depth penetration through multiple human head layers driven with low input power for safety treatments. In this work, we performed numerical modeling and computer simulations of a portable Meander Line antenna (MLA) to achieve the required EMF parameters to treat AD. The MLA device features a low cost, small size, wide bandwidth, and the ability to integrate into a portable system. This study utilized a High-Frequency Simulation System (HFSS) in the design of the MLA with the desired characteristics suited for AD treatment in humans. The team designed a 24-turn antenna with a 60 cm length and 25 cm width and achieved the required resonant frequency of 64 MHz. Here we used two numerical human head phantoms to test the antenna, the MIDA and spherical head phantom with six and seven tissue layers, respectively. The antenna was fed from a 50-Watt input source to obtain the SAR of 0.6 W/kg requirement in the center of the simulated brain tissue layer. We found that the E/H field and SAR distribution produced was not homogeneous; there were areas of high SAR values close to the antenna transmitter, also areas of low SAR value far away from the antenna. This paper details the antenna parameters, the scattering parameters response, the efficiency response, and the E and H field distribution; we presented the computer simulation results and discussed future work for a practical model.